Q&A: Shoreline Capital's Xiaolin Zhang
Xiaolin Zhang, co-founder and managing partner at China-focused distress specialist Shoreline Capital, discusses the NPL opportunity and what private equity firms must do to address it
Q: Shoreline's third fund closed at $500 million in mid-2015 (and was followed by an overflow vehicle of $200 million). What does the speed and nature of deployment say about overall trends in the market?...
More on Greater China
Latest News
Bain targets $102m Japan advertising take-private
Bain Capital has won board approval from Net Marketing, a Tokyo-listed online advertising and media management business, for a take-private that values the company at approximately JPY 13.6bn (USD 102m).
China's Insilico Medicine gets another $35m
Insilico Medicine, a China-based artificial intelligence-driven drug discovery company, has closed the second tranche of its Series D round on USD 35m, with Prosperity7 Ventures taking the lead.
Singapore crypto risk platform extends Series A to $24m
Singapore’s Merkle Science, a predictive crypto analytics platform, has raised USD 24m in Series A funding led by K3 Ventures, Darrow Holdings, and Beco Capital.
Cartesian seals deal for China rollout of restaurant chain Popeyes
Cartesian Capital Group, a US private equity firm that has served as Restaurant Brands International’s (RBI) joint venture partner for Burger King in China for the past decade, has been awarded exclusive country development rights for the company’s...